The Food and Drug Administration and the Centers for Disease Control and Prevention have called for a pause in Johnson & Johnson coronavirus vaccine distribution. This announcement comes after six recipients of the vaccine developed a rare blood clot disorder within two weeks of getting the shot.
Here & Now‘s Robin Young talks about what this interruption means with Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital and dean of the National School of Tropical Medicine at Baylor College of Medicine.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org. 9(MDA5MTc0MDI0MDEzMzE4MjI4ODdlOTk4MA004))